Inovexus

Inovexus is a Paris-based venture capital firm dedicated to fostering innovation within the early-stage startup ecosystem across both Europe and the United States. Positioned as a key player in "building the future of European early-stage funding," the firm actively seeks out and invests in companies demonstrating disruptive technologies and innovative business models. Their investment focus spans a diverse range of high-growth sectors, including Software-as-a-Service (SaaS), Artificial Intelligence (AI), Fintech, Healthcare, and Deep Tech.

The firm's investment philosophy extends beyond mere capital provision. Inovexus prides itself on offering comprehensive support to its portfolio companies, encompassing strategic guidance and operational assistance designed to help entrepreneurs effectively scale their businesses. The team comprises a blend of experienced entrepreneurs, seasoned investors, and industry experts, bringing a wealth of knowledge and practical insights to the startups they back. This hands-on approach aims to accelerate growth and navigate the complexities of early-stage development.

Inovexus typically targets seed and early-stage venture rounds, providing initial cheques that generally range from approximately $108,000 to $540,000 (equivalent to €100,000 to €500,000). As of early 2024, the firm has made over 15 investments, demonstrating a consistent commitment to its investment thesis. While primarily participating in rounds, Inovexus has also taken a lead investor position in at least one of its portfolio companies, showcasing its capacity to anchor funding rounds for promising ventures.